Gossez M, Bonnet B, Boussaid I, Chapuis N, Cointe S, Cravat M, De Carvalho Bittencourt M, Dignat-George F, Evrard B, Jeannet R, Jourdi G, Lozano C, Paul S, Siguret V, Waeckel L, Monneret G

Cytometry B Clin Cytom. 2024 06 24;:

Highly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation.

Notarantonio AB, Bertrand A, Piucco R, Fievet G, Sartelet H, Boulangé L, de Isla N, De Carvalho Bittencourt M, Hergalant S, Rubio MT, D'Aveni M

Exp Hematol Oncol. 2024 05 11;13(1):50

On behalf of the SFGM-TC: Real-life use of third-party virus-specific T-cell transfer in immunocompromised transplanted patients.

Leroyer EH, Petitpain N, Morisset S, Neven B, Castelle M, Winter S, Souchet L, Morel V, Le Cann M, Fahd M, Yacouben K, Mechinaud F, Ouachée-Chardin M, Renard C, Wallet HL, Angoso M, Jubert C, Chevallier P, Léger A, Rialland F, Dhedin N, Robin C, Maury S, Beckerich F, Beauvais D, Cluzeau T, Loschi M, Fernster A, Bittencourt MC, Cravat M, Bilger K, Clément L, Decot V, Gauthier M, Legendre A, Larghero J, Ouedrani A, Martin-Blondel G, Pochon C, Reppel L, Rouard H, Nguyen-Quoc S, Dalle JH, D'Aveni M, Bensoussan D

Hemasphere. 2024 01;8(1):e40

Efficacy of Wharton Jelly Mesenchymal Stromal Cells infusions in moderate to severe SARS-Cov-2 related acute respiratory distress syndrome: a phase 2a double-blind randomized controlled trial.

Pochon C, Laroye C, Kimmoun A, Reppel L, Dhuyser A, Rousseau H, Gauthier M, Petitpain N, Chabot JF, Valentin S, de Carvalho Bittencourt M, Peres M, Aarnink A, Decot V, Bensoussan D, Gibot S

Front Med (Lausanne). 2023 08 29;10:1224865

Age-related immune cell dynamics influence outcomes after allogeneic haematopoietic cell transplantation.

Jandin A, Pochon C, Campidelli A, D'Aveni M, Kicki C, Notarantonio AB, Roth Guepin G, Mbuyi TA, Feugier P, Chastagner P, Schweitzer C, de Carvalho Bittencourt M, Rubio MT, Pagliuca S

Br J Haematol. 2023 04 24;:

Allogeneic stem cell transplantation-A curative treatment for paroxysmal nocturnal hemoglobinuria with PIGT mutation: A case report.

Schenone L, Notarantonio AB, Latger-Cannard V, Fremeaux-Bacchi V, De Carvalho-Bittencourt M, Rubio MT, Muller M, D'Aveni M

World J Clin Cases. 2022 06 16;10(17):5702-5707

Relationship between clinical remission of perianal fistulas in Crohn's disease and serum adalimumab concentrations: A multi-center cross-sectional study.

Sirmai L, Pelletier AL, Gault N, Zallot C, Bouguen G, Bouchard D, Roland Nicaise P, Peyneau M, Sironneau S, Bittencourt MC, Petitcollin A, Fernandez P, Roblin X, Siproudhis L, Abramowitz L

World J Gastroenterol. 2022 Mar 7;28(9):961-972

CAR-T Cells Microscopic and Phenotypic Identification in the Peripheral Blood.

Lesesve JF, Cravat M, Boulangé L, Rubio MT, De Carvalho M

Mediterr J Hematol Infect Dis. 2022 ;14(1):e2022024

An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management.

Decker P, Moulinet T, Pontille F, Cravat M, Bittencourt MC, Jaussaud R

Autoimmun Rev. 2021 Dec 9;:103013

Post-SARS-CoV-2 vaccination specific antibody decrease : let's get the half-full glass perspective.

Béné MC, Bittencourt MC, Chevallier P

J Infect. 2021 Jul 28;:

Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases.

Decker P, Moulinet T, Lopez B, Dubucquoi S, Bonnotte B, Lakomy D, Revuz S, Luc A, Bittencourt MC, Hachulla E, Jaussaud R

Eur J Intern Med. 2021 May 7;:

Antiviral and Immunomodulatory Effects of Phytochemicals from Honey against COVID-19: Potential Mechanisms of Action and Future Directions.

Al-Hatamleh MAI, Hatmal MM, Sattar K, Ahmad S, Mustafa MZ, Bittencourt MC, Mohamud R

Molecules. 2020 Oct 29;25(21):

Good IgA bad IgG in SARS-CoV-2 infection?

Béné MC, de Carvalho M, Eveillard M, Lebri Y

Clin. Infect. Dis.. 2020 Apr 11;:

Mobilized Multipotent Hematopoietic Progenitors Promote Expansion and Survival of Allogeneic Tregs and Protect Against Graft Versus Host Disease.

D'Aveni M, Notarantonio AB, Agbogan VA, Bertrand A, Fouquet G, Gastineau P, Garfa-Traoré M, De Carvalho M, Hermine O, Rubio MT, Zavala F

Front Immunol. 2020 ;11:607180

ACPA-positive versus ACPA-negative rheumatoid arthritis: two distinct erosive disease entities on radiography and ultrasonography.

Grosse J, Allado E, Roux C, Pierreisnard A, Couderc M, Clerc-Urmes I, Remen T, Albuisson É, De Carvalho-Bittencourt M, Chary-Valckenaere I, Loeuille D

Rheumatol. Int.. 2019 Dec 13;:

Distinct prognostic value of circulating anti-telomerase CD4 Th1 immunity and exhausted PD-1/TIM-3 T cells in lung cancer.

Laheurte C, Dosset M, Vernerey D, Boullerot L, Gaugler B, Gravelin E, Kaulek V, Jacquin M, Cuche L, Eberst G, Jacoulet P, Fabre E, Le Pimpec-Barthes F, Tartour E, De Carvalho Bittencourt M, Westeel V, Adotévi O

Br. J. Cancer. 2019 Jul 30;:

Vedolizumab Trough Levels and Histological Healing During Maintenance Therapy in Ulcerative Colitis.

Pouillon L, Rousseau H, Busby-Venner H, De Carvalho Bittencourt M, Choukour M, Gauchotte G, Zallot C, Danese S, Baumann C, Peyrin-Biroulet L

J Crohns Colitis. 2019 Jan 29;:

Epidemiological data of anaphylaxis in french emergency departments.

Corriger J, Beaudouin E, Rothmann C, Penven E, Haumonte Q, Thomas H, Picaud J, Nguyen-Grosjean VM, Corriger-Ippolito J, Braun F, De Talancé M, Auburtin B, Atain-Kouadio P, Borsa-Dorion A, Baugnon D, De Carvalho M, Jaussaud R, Nguyen-Thi PL, Bollaert PE, Demoly P, Kase Tanno L

J Investig Allergol Clin Immunol. 2018 Nov 9;:0

Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study.

Yacoub W, Williet N, Pouillon L, Di-Bernado T, De Carvalho Bittencourt M, Nancey S, Lopez A, Paul S, Zallot C, Roblin X, Peyrin-Biroulet L

Aliment. Pharmacol. Ther.. 2018 Apr;47(7):906-912

An Early Immediate Early Protein IE-1-Specific T-Cell Polyfunctionality Is Associated With a Better Control of Cytomegalovirus Reactivation in Kidney Transplantation.

Dekeyser M, Ladrière M, Audonnet S, Frimat L, De Carvalho Bittencourt M

Kidney Int Rep. 2017 May;2(3):486-492

Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial.

Qian C, Campidelli A, Wang Y, Cai H, Venard V, Jeulin H, Dalle JH, Pochon C, D'aveni M, Bruno B, Paillard C, Vigouroux S, Jubert C, Ceballos P, Marie-Cardine A, Galambrun C, Cholle C, Clerc Urmes I, Petitpain N, De Carvalho Bittencourt M, Decot V, Reppel L, Salmon A, Clement L, Bensoussan D

J Hematol Oncol. 2017 May;10(1):102

A rare case of extremely high counts of circulating tumor cells detected in a patient with an oral squamous cell carcinoma.

Wu X, Mastronicola R, Tu Q, Faure GC, De Carvalho Bittencourt M, Dolivet G

BMC Cancer. 2016 Jul;16:552

Diagnostic and Prognostic Value of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: a systematic review and meta-analysis.

Wu XL, Tu Q, Faure G, Gallet P, Kohler C, Bittencourt Mde C

Sci Rep. 2016 Feb;6:20210

Adenovirus-specific T-cell Subsets in Human Peripheral Blood and After IFN-γ Immunomagnetic Selection.

Qian C, Wang Y, Cai H, Laroye C, De Carvalho Bittencourt M, Clement L, Stoltz JF, Decot V, Reppel L, Bensoussan D

J. Immunother.. 2016 Jan;39(1):27-35

CellSearch technology applied to the detection and quantification of tumor cells in CSF of patients with lung cancer leptomeningeal metastasis.

Tu Q, Wu X, Le Rhun E, Blonski M, Wittwer B, Taillandier L, De Carvalho Bittencourt M, Faure GC

Lung Cancer. 2015 Sep 14. pii: S0169-5002(15)30052-0

Combination of CD160 and CD200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B-cell neoplasms.

Lesesve JF, Tardy S, Frotscher B, Latger-Cannard V, Feugier P, De Carvalho Bittencourt M

Int J Lab Hematol. 2014 Dec 3

Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.

Wang Y, Aissi-Rothe L, Virion JM, De Carvalho Bittencourt M, Ulas N, Audonnet S, Salmon A, Clement L, Venard V, Jeulin H, Stoltz JF, Decot V, Bensoussan D

Cytotherapy. 2014 Jan;16(1):122-34

Three weeks of murine hindlimb unloading induces shifts from B to T and from th to tc splenic lymphocytes in absence of stress and differentially reduces cell-specific mitogenic responses.

Gaignier F, Schenten V, De Carvalho Bittencourt M, Gauquelin-Koch G, Frippiat JP, Legrand-Frossi C

PLoS One. 2014 Mar 24;9(3):e92664

Value of HIV patients with regular follow-up as in-house internal controls of flow cytometry measurement of lymphocyte subsets.

de Carvalho Bittencourt M, Kohler C, Henard S, Rabaud C, Bene MC, Faure GC

Cytometry B Clin Cytom. 2013 Sep-Oct;84(5):324-6

Value of HIV patients with regular follow-up as in-house internal controls of flow cytometry measurement of lymphocyte subsets.

de Carvalho Bittencourt M, Kohler C, Henard S, Rabaud C, Bene MC, Faure GC

Cytometry B Clin Cytom. 2013 Jul 8

Detection and quantification of CSF malignant cells by the CellSearch technology in patients with melanoma leptomeningeal metastasis.

Le Rhun E, Tu Q, De Carvalho Bittencourt M, Farre I, Mortier L, Cai H, Kohler C, Faure GC

Med Oncol. 2013 Jun;30(2):538

Combination biomarkers to diagnose sepsis in the critically ill patient.

Gibot S, Bene MC, Noel R, Massin F, Guy J, Cravoisy A, Barraud D, De Carvalho Bittencourt M, Quenot JP, Bollaert PE, Faure G, Charles PE

Am J Respir Crit Care Med. 2012 Jul 1;186(1):65-71

Active Toll-like receptor-7 triggering of chronic lymphocytic leukemia B-cells by imiquimod.

Chen M, Bittencourt Mde C, Feugier P, Faure GC, Bene MC

Leuk Lymphoma. 2012 Apr;53(4):739-42.

Decreased peripheral dendritic cell numbers in dengue virus infection.

De Carvalho Bittencourt M, Martial J, Cabie A, Thomas L, Cesaire R

J Clin Immunol. 2012 Feb;32(1):161-72

Follicular proinflammatory cytokines and chemokines as markers of IVF success.

Sarapik A, Velthut A, Haller-Kikkatalo K, Faure GC, Bene MC, de Carvalho Bittencourt M, Massin F, Uibo R, Salumets A

Clin Dev Immunol. 2012;2012:606459

Normal levels of peripheral CD19(+) CD5(+) CLL-like cells: toward a defined threshold for CLL follow-up -- a GEIL-GOELAMS study.

Durrieu F, Genevieve F, Arnoulet C, Brumpt C, Capiod JC, Degenne M, Feuillard J, Garand R, Kara-Terki A, Kulhein E, Maynadie M, Ochoa-Noguera ME, Plesa A, Roussel M, Eghbali H, Truchan-Graczyk M, de Carvalho Bittencourt M, Feugier P, Bene MC

Cytometry B Clin Cytom. 2011 Nov;80(6):346-53

Long term culture of mesenchymal stem cells in hypoxia promotes a genetic program maintaining their undifferentiated and multipotent status.

Basciano L, Nemos C, Foliguet B, de Isla N, de Carvalho M, Tran N, Dalloul A

BMC Cell Biol.. 2011 Mar 30;12:12

Reduced levels of both circulating CD4+ CD25+ CD127(low/neg) and CD4+ CD8(neg) invariant natural killer regulatory T cells in stable heart transplant recipients.

Chen M, Mohtize M, Mattei MF, Villemot JP, Kohler C, Faure GC, Bene MC, de Carvalho Bittencourt M

Clin Exp Immunol. 2011 Jan;163(1):104-12

Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion.

Kleinclauss F, Perruche S, Masson E, de Carvalho Bittencourt M, Biichle S, Remy-Martin JP, Ferrand C, Martin M, Bittard H, Chalopin JM, Seilles E, Tiberghien P, Saas P

Cell Death Differ. 2006 Jan;13(1):41-52.

Extracellular lysosome-associated membrane protein-1 (LAMP-1) mediates autoimmune disease progression in the NOD model of type 1 diabetes.

De Carvalho Bittencourt M, Herren S, Graber P, Vilbois F, Pasquali C, Berney C, Plitz T, Nicoletti F, Kosco-Vilbois MH

Eur J Immunol. 2005 May;35(5):1501-9.

Intravenous infusion of apoptotic cells simultaneously with allogeneic hematopoietic grafts alters anti-donor humoral immune responses.

Perruche S, Kleinclauss F, Bittencourt Mde C, Paris D, Tiberghien P, Saas P

Am. J. Transplant.. 2004 Aug;4(8):1361-5